Tumor Necrosis Factor-Related Apoptosis Inducing Ligand in Systemic Lupus Erythematosus Patients; Potential Role in Disease Activity, Neutropenia and Renal Impairment

Serum levels of soluble CD95 in patients with systemic lupus erythematosus

Interleukin-22 and Tumor Necrosis Factor Receptor Associated Factor 1 (TRAF1) in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation with Disease Activity

Study of tumor necrosis factor-related apoptosis inducing ligand (TRAIL) MRNA expression in patients with systemic lupus erythematosus

Dysregulation of Tumor Necrosis Factor Alpha-Induced Protein 3 mRNA Expression in Lupus Nephritis in Relation to Clinic-pathologic Characteristics and Disease Activity of Systemi

Relationship between serum levels of T Cell Immunoglobulin and Mucin-Domain Containing Molecule-3 and Systemic Lupus Erythematosus

Serum lipoxin A4 as a biomarker for systemic lupus erythematosus

Possible involvement of IL-18 in SLE-dysregulated apoptosis and cytopenia

Serum Levels of Soluble Fractalkine in Patients with Systemic Lupus Erythematosus

SERUM INTERLEUKIN-18 AS A NOVEL BIOMARKER FOR DISEASE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS